Глава 9
1. Maud D. van Zijl, Bouchra Koullali, Christiana A. Naaktgeboren, Ewoud Schuit et al. Pessary or Progesterone to Prevent Preterm delivery in women with short cervical length: the Quadruple P randomised controlled trial. BMC Pregnancy Childbirth. 2017 Sep 4; 17(1): 284. doi: 10.1186/s12884-017-1454-x.
2. Natasha L. Hezelgrave, Helena A. Watson, Alexandra Ridout, Falak Diab, Paul T. Seed et al. Rationale and design of SuPPoRT: a multi-centre randomised controlled trial to compare three treatments: cervical cerclage, cervical pessary and vaginal progesterone, for the prevention of preterm birth in women who develop a short cervix. BMC Pregnancy Childbirth. 2016 Nov 21; 16(1): 358. doi: 10.1186/s12884-016-1148-9.
3. Lourdes Cabrera-García, Sara Cruz-Melguizo, Belén Ruiz-Antorán et al. Evaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (PESAPRO Trial): study protocol for a randomized controlled trial. Trials. 2015 Sep 25; 16: 427. doi: 10.1186/s13063-015-0964-y.
4. Gabriele Saccone, Giuseppe Maria Maruotti, Antonia Giudicepietro, Pasquale Martinelli et al. Effect of Cervical Pessary on Spontaneous Preterm Birth in Women With Singleton Pregnancies and Short Cervical Length: A Randomized Clinical Trial. JAMA. 2017 Dec 19; 318(23): 2317–2324. doi: 10.1001/jama.2017.18956.
5. Romero R., Nicolaides K.H., Conde-Agudelo A., O’Brien J.M. et al. Vaginal progesterone decreases preterm birth ≤34 weeks of gestation in women with a singleton pregnancy and a short cervix: an updated meta-analysis including data from the OPPTIMUM study. Ultrasound Obstet Gynecol. 2016 Sep; 48(3): 308–17. doi: 10.1002/uog.15953. Epub 2016 Jul 19.
6. Roberto Romero, Agustin Conde-Agudelo, Eduardo Da Fonseca et al. Vaginal progesterone for preventing preterm birth and adverse perinatal outcomes in singleton gestations with a short cervix: a meta-analysis of individual patient data. Am J Obstet Gynecol. 2018 Feb; 218(2): 161–180. doi: 10.1016/j.ajog.2017.11.576. Epub 2017 Nov 17.
7. Banicevic A.C., Popovic M., Ceric A. Cervical Length Measured by Transvaginal Ultrasonography and Cervicovaginal Infection as Predictor of Preterm Birth Risk. Acta Inform Med. 2014 Apr; 22(2): 128–132. [PMID: 24825940].
8. Cervical insufficiency and cervical cerclage. SOGC Clinical Practice Guidelines. Richard Brown, Robert Gagnon, Marie-France Delisle/J Obstet Gynaecol Can 2013; 35(12): 1115–1127. doi: 10.1016/S1701-2163(15)30764-7.
9. Kagan K.O., Sonek J. How to measure cervical length Ultrasound in Obstetrics @ Gynecology. Vol. 45, Issue 3. March 2015. P. 358–362.
10. Lee S. E., Romero R., Park C. W. et al. The frequency and significance of intraamniotic inflammation in patients with cervical insufficiency // Am. J. Obstet. Gynecol. 2008. Vol. 198. P. 633e1–633e8. [PMID: 18342290].
11. Brown R., Gagnon R., Delisle M. F. Cervical insufficiency andcervical cerclage // J. Obstet. Gynaecol. Can. 2013. Vol. 35. № 12. P. 1115–1127. PMID: 24405880.
12. Diagnosis and Management of Cervical Insufficiency. Canterbury District Health Board, April, 2017.
13. Абдрахимова Я.Н., Суздальцева М.В. Истмико-цервикальная недостаточность, современное состояние проблемы // Актуальные проблемы теоретической, экспериментальной, клинической медицины и фармации. 2018. Т. 12, № 2. С. 24–29.
14. Беспалова О.Н., Саргсян Г.С. Выбор метода коррекции истмико-цервикальной недостаточности // Журнал акушерства и женских болезней. 2017. Т. 66, № 3. С. 157–168. doi: 10.17816/JOWD663157-168.
15. Практическая кольпоскопия / С.И. Роговская. 4-е изд., испр. и доп. М.: ГЭОТАР-Медиа, 2016. 256 с. (Серия «Библиотека врача-специалиста»). ISBN 978-5-9704-3724-7.23.
16. Jakobsson М., Norwitz E.R. Cervical intraepithelial neoplasia: Reproductive effects of treatment. Up to date May 2014.
17. FIGO Working Group on Best Practice… // Int. J. Gynecol. Obstet. 2015. Vol. 128. P. 80–82. [PMID: 25481030].
18. Chan Y.Y., Jayaprakasan K., Tan A. et al. Reproductive outcomes in women with congenital uterine anomalies: a systematic review. Ultrasound Obstet Gynecol. 2011. 38. P. 371.
19. Devoto L. Luteal phase physiology and its relevance for steroids and human chorionic gonadotropin treatment // Gynecol. Endocrinol. 2008. Vol. 24. № 5. P. 237–238. [PMID: 18569026].
20. De Vos M., Nuytinck L., Verellen C., De Paepe A. Preterm premature rupture of membranes in a patient with the hypermobility type of the Ehlers-Danlos syndrome. A case report. Fetal Diagn Ther. 1999; 14: 244–247.
21. Warren J.E. (2007) Collagen 1Alpha1 and transforming growth factor-beta polymorphisms in women with cervical insufficiency. PMID: 17766609.
22. Warren J.E. (2009) Genetics of the cervix in relation to preterm birth. PMID: 19796727.
23. Miller R. The association of beta-2 adrenoceptor genotype with short-cervix mediated preterm birth: a case-control study. PMID: 25600430.
24. Williams Obstetrics. 24th ed. 2014. 1377 p.
25. Gernand A.D., Schulze K.J., Stewart C.P. et al. Micronutrient deficiencies in pregnancy worldwide: health effects and prevention // Nat. Rev. Endocrinol. 2016. Vol. 12. № 5. P. 274–289. [PMID: 27032981].